healthline Hims & Hers to Stop Selling Compounded Obesity Pill Amid Regulatory Scrutiny and Other Health Controversies
Telehealth company Hims & Hers will cease sales of its compounded version of Novo Nordisk's obesity pill, Wegovy, following a request by the US Department of Health and Human Services (HHS) for the Justice Department to probe the company's practices. This development comes amidst a broader landscape of controversy in healthcare, including debates over gender-affirming care, concerns about the integrity of medical research, and scrutiny of pharmaceutical pricing.